title: Authors' Reply to "Infliximab in the Treatment of Refractory Ocular Inflammatory Diseases".
authors.affiliation: Department of Ophthalmology & Visual Sciences Prince of Wales Hospital The Chinese University of Hong Kong Division of Rheumatology The Department of Medicine and Therapeutics Prince of Wales Hospital The Chinese University of Hong Kong.
authors.forename: Ka Wai
authors.initials: KW
authors.lastname: Kam
authors.forename: Alvin L
authors.initials: AL
authors.lastname: Young
authors.forename: Lai Shan
authors.initials: LS
authors.lastname: Tam
authors.forename: Patrick Mang Kwan
authors.initials: PM
authors.lastname: Tam
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D007634:Keratitis / Q000188:drug therapy*; D008297:Male; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D000069285:Infliximab